{"meta":{"query_hash":"4a1c6d30377f","filters":{"venue":"Medicine in Drug Discovery"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4a1c6d30377f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Medicine+in+Drug+Discovery"},"results":[{"id":"W3166614645","doi":"10.1016/j.medidd.2021.100094","title":"Acanthopanax senticosus polysaccharide-loaded calcium carbonate nanoparticle as an adjuvant to enhance porcine parvovirus vaccine immune responses","year":2021,"lang":"en","type":"article","venue":"Medicine in Drug Discovery","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Henan Provincial Science and Technology Research Project; Key Scientific Research Project of Colleges and Universities in Henan Province; National Natural Science Foundation of China","keywords":"Immune system; Adjuvant; Polyethylenimine; Immunopotentiator; Immunogenicity; Antigen; Materials science; Porcine parvovirus; Microbiology; Chemistry; Biology; Immunology; Antibody; Biochemistry; Transfection","score_opus":0.013131482544877032,"score_gpt":0.3041231515182059,"score_spread":0.29099166897332884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166614645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915576,0.002526643,0.004216466,0.000118596494,0.00005559004,0.00006994238,0.000052108135,0.000060635462,0.0013424552],"genre_scores_gemma":[0.9938147,0.0011161962,0.0039207777,0.00007094619,0.00001861737,0.000043853353,0.00006354307,0.000008442212,0.0009428807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999392,0.0000076649085,0.000004085328,0.000010973465,0.000023528033,0.000014583191],"domain_scores_gemma":[0.99997497,0.0000034278985,0.0000060166944,0.0000016131856,0.000005605037,0.000008416283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009437789,0.00028455566,0.00017843542,0.00022022743,0.00009713634,0.00011264109,0.00015319955,0.00032102037,0.00035421425],"category_scores_gemma":[0.00007849692,0.000094827956,0.00021052164,0.0001142061,0.00012901856,0.00018207887,0.00014816926,0.00025041704,0.00007850217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003001124,0.000020496553,0.000045173056,0.00006580023,0.0000038386916,0.000027219843,0.000008087359,0.00012942859,0.9980507,0.00005709146,0.00003966527,0.0015226118],"study_design_scores_gemma":[0.00003482953,0.0007175122,0.0017983093,0.0000085081265,0.000039376464,0.00013001899,0.000013911187,0.0043856753,0.9897261,0.000053200496,0.0030819743,0.00001053918],"about_ca_topic_score_codex":0.00045549584,"about_ca_topic_score_gemma":0.00066879636,"teacher_disagreement_score":0.00045549584,"about_ca_system_score_codex":0.0001966259,"about_ca_system_score_gemma":0.00016486568,"threshold_uncertainty_score":0.0014265776},"labels":[],"label_agreement":null},{"id":"W4392184550","doi":"10.1016/j.medidd.2024.100182","title":"Insights from clinical trials: New evidence supports surgical interventions over drug therapies for atrial fibrillation","year":2024,"lang":"en","type":"article","venue":"Medicine in Drug Discovery","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Atrial fibrillation; Medicine; Drug; Clinical trial; Psychological intervention; Drug trial; Intensive care medicine; Cardiology; Internal medicine; Pharmacology; Psychiatry","score_opus":0.240620048756248,"score_gpt":0.49524043031239895,"score_spread":0.25462038155615097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392184550","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008457428,0.9497184,0.0017243478,0.0377557,0.0038746232,0.00027553856,0.00039139675,0.000025659943,0.0053885155],"genre_scores_gemma":[0.040082417,0.8906484,0.0057639885,0.048247185,0.01318948,0.0006522,0.00047461796,0.00007325378,0.00086836226],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.92548645,0.04574003,0.012675898,0.0039870664,0.011135531,0.0009751717],"domain_scores_gemma":[0.44599706,0.49720794,0.02535561,0.0074549746,0.0209808,0.0030036287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.085452214,0.001583814,0.0064519313,0.004061804,0.0008919865,0.010644759,0.002624431,0.0061802748,0.017868878],"category_scores_gemma":[0.26988873,0.0009697996,0.0050310437,0.004387118,0.0039666235,0.010563947,0.0029161286,0.009272424,0.002284399],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004849705,0.00028309858,0.0061095115,0.24841273,0.015002134,0.00034656568,0.00068498915,0.00067761145,0.00054054195,0.043758065,0.050932493,0.6284026],"study_design_scores_gemma":[0.0034392916,0.0023355978,0.010788425,0.51641685,0.026894793,0.0007103575,0.0009774456,0.000795853,0.0005726943,0.0814246,0.3554838,0.00016037661],"about_ca_topic_score_codex":0.0016611749,"about_ca_topic_score_gemma":0.0033019483,"teacher_disagreement_score":0.085452214,"about_ca_system_score_codex":0.003984385,"about_ca_system_score_gemma":0.00897541,"threshold_uncertainty_score":0.4519199},"labels":[],"label_agreement":null},{"id":"W4417397374","doi":"10.1016/j.medidd.2025.100244","title":"Toward peptide-based protein replacement in fragile X syndrome: Evaluating the N-tat strategy","year":2025,"lang":"en","type":"article","venue":"Medicine in Drug Discovery","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"FPInnovations","funders":"","keywords":"Fragile X syndrome; Interactome; Fragile x; Translation (biology); Peptide; Messenger RNA; Protein–protein interaction; In vivo","score_opus":0.019488808959218704,"score_gpt":0.298543531835194,"score_spread":0.27905472287597527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417397374","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38436228,0.4815158,0.075540274,0.021017969,0.0052448194,0.00041186553,0.00039097737,0.00048282646,0.03103326],"genre_scores_gemma":[0.6300761,0.31681308,0.030155336,0.0062054694,0.000888764,0.00018717916,0.00038209136,0.00012606454,0.0151659595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997912,0.00006883629,0.000015067806,0.000029211682,0.000065696266,0.000030107389],"domain_scores_gemma":[0.99990606,0.00003738439,0.000014156426,0.0000050734097,0.000022860488,0.000014348685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007867346,0.0002702392,0.0002833623,0.00015168883,0.00021810539,0.00056264043,0.00038785735,0.00082704576,0.00097565394],"category_scores_gemma":[0.00045209343,0.00011022014,0.00029542597,0.00009636174,0.0004356644,0.000595807,0.00038642352,0.00095821643,0.00041685635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009424706,0.00021995495,0.0005643052,0.0022486772,0.000113842754,0.00283796,0.0005111385,0.0046985946,0.7545503,0.029918754,0.010426818,0.1929671],"study_design_scores_gemma":[0.00026329755,0.005311369,0.000677434,0.00053832924,0.00022594907,0.007462221,0.00026145892,0.004406573,0.5095082,0.007116068,0.46414238,0.00008669769],"about_ca_topic_score_codex":0.0004452725,"about_ca_topic_score_gemma":0.00083286996,"teacher_disagreement_score":0.00097565394,"about_ca_system_score_codex":0.000439905,"about_ca_system_score_gemma":0.00038792685,"threshold_uncertainty_score":0.004160702},"labels":[],"label_agreement":null}]}